In vitro resistance study of rupintrivir, a novel inhibitor of human rhinovirus 3C protease.
about
Respiratory virus modulation of host nucleocytoplasmic transport; target for therapeutic intervention?Recent developments in antiviral agents against enterovirus 71 infectionStructural Basis for Antiviral Inhibition of the Main Protease, 3C, from Human Enterovirus 93Luteoloside Acts as 3C Protease Inhibitor of Enterovirus 71 In VitroRupintrivir is a promising candidate for treating severe cases of Enterovirus-71 infection.Peptidyl aldehyde NK-1.8k suppresses enterovirus 71 and enterovirus 68 infection by targeting protease 3CPhosphatidylinositol 4-kinase III beta is essential for replication of human rhinovirus and its inhibition causes a lethal phenotype in vivo.Real-time monitoring of human enterovirus (HEV)-infected cells and anti-HEV 3C protease potency by fluorescence resonance energy transfer.Modeling of the human rhinovirus C capsid suggests possible causes for antiviral drug resistance.Picornaviral 3C protease inhibitors and the dual 3C protease/coronaviral 3C-like protease inhibitors.The enterovirus protease inhibitor rupintrivir exerts cross-genotypic anti-norovirus activity and clears cells from the norovirus replicon.The enterovirus 3C protease inhibitor SG85 efficiently blocks rhinovirus replication and is not cross-resistant with rupintrivir.Proteases and protease inhibitors in infectious diseases.Selection and Characterization of Rupintrivir-Resistant Norwalk Virus Replicon Cells In Vitro.Emerging antiviral drugs
P2860
Q26796151-DD988493-6490-47AC-A99D-66008E99808DQ26849627-84419D15-1BE1-417E-8198-AC8A4C469FAAQ27671687-B003F6B1-2A7D-41E8-A470-AC75B5CEA7BCQ28550132-93D7B4CE-9E54-4799-80A0-3FEBC4A04C95Q33590806-0ACD31EF-316D-4C21-B413-E5CC266AFE8DQ35385360-4035320D-B207-4EBF-8BA1-20E1ACBB064EQ36970004-A9A9EBEE-B98C-42AA-80FF-65051A58CA6EQ37072075-64859C04-C2D1-43CE-AEAC-139E516F5902Q37425455-2B68CD55-D0C0-4345-AF43-7824E304E2B9Q37658853-38635904-3C8C-44E2-A7CA-642B94AFC076Q38988957-775E44A0-9478-4238-9BC8-0DD0A784561AQ41175433-9735C858-9AF8-45DD-95E3-CDDC49C24011Q47576680-B76304A0-9A45-4F81-9CE0-F1757D8F7062Q52659751-3E1A09E2-B0F7-4031-A5A3-36962CD664AAQ56786308-8234A608-2FAB-4D4B-BF75-8EF3F28B3ED4
P2860
In vitro resistance study of rupintrivir, a novel inhibitor of human rhinovirus 3C protease.
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
In vitro resistance study of r ...... human rhinovirus 3C protease.
@ast
In vitro resistance study of r ...... human rhinovirus 3C protease.
@en
type
label
In vitro resistance study of r ...... human rhinovirus 3C protease.
@ast
In vitro resistance study of r ...... human rhinovirus 3C protease.
@en
prefLabel
In vitro resistance study of r ...... human rhinovirus 3C protease.
@ast
In vitro resistance study of r ...... human rhinovirus 3C protease.
@en
P2093
P2860
P356
P1476
In vitro resistance study of r ...... human rhinovirus 3C protease.
@en
P2093
Binford SL
Brothers MA
Maldonado F
Matthews DA
P2860
P304
P356
10.1128/AAC.00905-07
P407
P577
2007-10-01T00:00:00Z